Superworth

Kairos Pharma, LTD. price to book ratio KAPA

Market value divided by the book value of the company's net assets, since 2024.

Today, Nov 2, 2026
0.4×
Peer median
0.4×

Kairos Pharma, LTD.'s price to book ratio is 0.4× as of Nov 2, 2026.

The median for 3 healthcare stocks of a similar size is 0.4×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.4×0.4×2.4×
20251.9×1.1×6.7×
20246.5×5.6×6.6×

Against its peers

Companies in Healthcare nearest Kairos Pharma, LTD.'s size, closest first, today.

CompanyPrice to book ratio
KAPAKairos Pharma, LTD.0.4×
OXBROXBRIDGE RE HOLDINGS1.0×
EDUCEducational Development0.2×
GTIMGood Times Restaurants0.4×
Peer median0.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Kairos Pharma, LTD.

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.